Tuesday, December 11, 2012
La Jolla Pharmaceutical Co., of San Diego, released $2.9 million in cash to fund operations through an agreement with holders of preferred stock to waive their right to redeem the stock on Jan. 20, 2013.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.